Jolyn S Taylor1, Alaina J Brown2, Lauren S Prescott2, Charlotte C Sun2, Lois M Ramondetta2, Diane C Bodurka3. 1. The Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: Jstaylor1@mdanderson.org. 2. The Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. 3. The Department of Medical Education, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Abstract
OBJECTIVE: To identify disparities in utilization of end of life (EoL) resources by gynecologic oncology (GO) patients. METHODS: This retrospective analysis of the medical records of GO patients treated 1/2007-12/2011 and deceased 1/2012-8/2014 evaluated patient demographics, disease characteristics, and utilization of EoL resources. Chi-square, Fisher's exact test, Mann Whitney and Kruskal-Wallis tests were used for statistical analysis. RESULTS: Of 189 patients analyzed, 113 (60%) were white, 38 (20%) Hispanic, 31 (16%) black, and seven (4%) Asian. Ninety-five (48%) had ovarian cancer, 51 (26%) uterine, 47 (23%) cervical, seven (3%) vulvar/vaginal. In the last 30days of life (DoL), 18 (10%) had multiple hospital admissions, 10 (5%) admitted to the Intensive Care Unit (ICU), 30 (16%) multiple Emergency Room (ER) visits, 45 (24%) received aggressive medical care and eight (4%) received chemotherapy in the final 14 DoL. Furthermore, 54 (29%) had no Supportive Care referral and 29 (15%) no hospice referral. Only 46 (24%) had a Medical Power of Attorney (PoA) or Living Will (LW) on file. Non-white race was associated with increased odds of dying without hospice (OR 3.07; 95%CI [1.27, 2.46], p=0.013). However, non-white patients who enrolled in hospice did so earlier than white patients (42 v. 27days before death, p=0.054). Non-white patients were also significantly less likely to have PoA/LW documentation (24% v. 76%, p=0.009) even if enrolled in hospice (12% v. 31%, p=0.007). CONCLUSIONS: Significant racial disparities in hospice enrollment and PoA/LW documentation were seen in GO patients. This warrants further study to identify barriers to use of EoL resources.
OBJECTIVE: To identify disparities in utilization of end of life (EoL) resources by gynecologic oncology (GO) patients. METHODS: This retrospective analysis of the medical records of GO patients treated 1/2007-12/2011 and deceased 1/2012-8/2014 evaluated patient demographics, disease characteristics, and utilization of EoL resources. Chi-square, Fisher's exact test, Mann Whitney and Kruskal-Wallis tests were used for statistical analysis. RESULTS: Of 189 patients analyzed, 113 (60%) were white, 38 (20%) Hispanic, 31 (16%) black, and seven (4%) Asian. Ninety-five (48%) had ovarian cancer, 51 (26%) uterine, 47 (23%) cervical, seven (3%) vulvar/vaginal. In the last 30days of life (DoL), 18 (10%) had multiple hospital admissions, 10 (5%) admitted to the Intensive Care Unit (ICU), 30 (16%) multiple Emergency Room (ER) visits, 45 (24%) received aggressive medical care and eight (4%) received chemotherapy in the final 14 DoL. Furthermore, 54 (29%) had no Supportive Care referral and 29 (15%) no hospice referral. Only 46 (24%) had a Medical Power of Attorney (PoA) or Living Will (LW) on file. Non-white race was associated with increased odds of dying without hospice (OR 3.07; 95%CI [1.27, 2.46], p=0.013). However, non-white patients who enrolled in hospice did so earlier than white patients (42 v. 27days before death, p=0.054). Non-white patients were also significantly less likely to have PoA/LW documentation (24% v. 76%, p=0.009) even if enrolled in hospice (12% v. 31%, p=0.007). CONCLUSIONS: Significant racial disparities in hospice enrollment and PoA/LW documentation were seen in GO patients. This warrants further study to identify barriers to use of EoL resources.
Authors: Peri Rosenfeld; Jeanne Dennis; Suzanne Hanen; Ernesto Henriquez; Theresa M Schwartz; Lyla Correoso; Christopher M Murtaugh; Alan Fleishman Journal: Am J Hosp Palliat Care Date: 2007-06-29 Impact factor: 2.500
Authors: Kathleen M Fairfield; Kimberly M Murray; Heidi R Wierman; Paul K J Han; Sarah Hallen; Susan Miesfeldt; Edward L Trimble; Joan L Warren; Craig C Earle Journal: Gynecol Oncol Date: 2011-12-01 Impact factor: 5.482
Authors: Nancy E Morden; Chiang-Hua Chang; Joseph O Jacobson; Ethan M Berke; Julie P W Bynum; Kimberly M Murray; David C Goodman Journal: Health Aff (Millwood) Date: 2012-04 Impact factor: 6.301
Authors: Micael Lopez-Acevedo; Laura J Havrilesky; Gloria Broadwater; Arif H Kamal; Amy P Abernethy; Andrew Berchuck; Angeles Alvarez Secord; James A Tulsky; Fidel Valea; Paula S Lee Journal: Gynecol Oncol Date: 2013-04-13 Impact factor: 5.482
Authors: Craig C Earle; Bridget A Neville; Mary Beth Landrum; John Z Ayanian; Susan D Block; Jane C Weeks Journal: J Clin Oncol Date: 2004-01-15 Impact factor: 44.544
Authors: Alexi A Wright; Baohui Zhang; Alaka Ray; Jennifer W Mack; Elizabeth Trice; Tracy Balboni; Susan L Mitchell; Vicki A Jackson; Susan D Block; Paul K Maciejewski; Holly G Prigerson Journal: JAMA Date: 2008-10-08 Impact factor: 56.272
Authors: Benjamin Margolis; Ling Chen; Melissa K Accordino; Grace Clarke Hillyer; June Y Hou; Ana I Tergas; William M Burke; Alfred I Neugut; Cande V Ananth; Dawn L Hershman; Jason D Wright Journal: Am J Obstet Gynecol Date: 2017-07-11 Impact factor: 8.661
Authors: Erica C Kaye; Jonathan Jerkins; Courtney A Gushue; Samantha DeMarsh; April Sykes; Zhaohua Lu; Jennifer M Snaman; Lindsay Blazin; Liza-Marie Johnson; Deena R Levine; R Ray Morrison; Justin N Baker Journal: J Pain Symptom Manage Date: 2018-02-08 Impact factor: 3.612
Authors: Jolyn S Taylor; Suja S Rajan; Ning Zhang; Larissa A Meyer; Lois M Ramondetta; Diane C Bodurka; David R Lairson; Sharon H Giordano Journal: J Clin Oncol Date: 2017-04-07 Impact factor: 44.544
Authors: Michael G Cohen; Andrew D Althouse; Robert M Arnold; Hailey W Bulls; Douglas B White; Edward Chu; Margaret Q Rosenzweig; Kenneth J Smith; Yael Schenker Journal: Cancer Date: 2021-11-17 Impact factor: 6.860
Authors: Jessica Y Islam; Veeral Saraiya; Rebecca A Previs; Tomi Akinyemiju Journal: Int J Environ Res Public Health Date: 2021-06-04 Impact factor: 3.390